期刊文献+

心肌肌钙蛋白T与老年慢性心力衰竭预后的关系 被引量:1

Effect of cardiac troponin T on prognosis in the elderly patients with chronic heart failure
原文传递
导出
摘要 目的探讨心肌肌钙蛋白 T(cTnT)对老年慢性心力衰竭预后的影响。方法对60例不同心功能级别老年慢性心力衰竭患者测定血清 cTnT、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB),并根据 cTnT 是否阳性分组,比较其住院期间的心脏事件(恶性心律失常、心力衰竭反复或加重、死亡)的发生情况。结果心功能Ⅱ级者 CK(89.1±13.6)mmol/L,CK-MB(7.9±1.4)mmol/L,cTnT阳性0例;心功能Ⅲ级者 CK(88.2±13.4)mmol/L,CK-MB(7.5±1.8)mmol/L,cTnT 阳性4例;心功能Ⅳ级者 CK-MB(8.0±1.6)mmol/L,CK(93.3±14.2)mmol/L,cTnT 阳性14例。cTnT 阳性组恶性心律失常发生6例(33.3%),心力衰竭反复或加重8例(44.4%),死亡3例(16.7%);cTnT 阴性组恶性心律失常发生1例(2.4%),心力衰竭反复或加重2例(4.8%),死亡1例(2.4%)。cTnT 阳性组心脏事件发生率高于 cTnT 阴性组(P<0.05)。结论 cTnT 与老年慢性心力衰竭的预后有密切的关系,对判断估测老年慢性心力衰竭患者预后有较好的预测价值。 Objective To study the effect of cardiac troponin T (cTnT) on the prognosis of chronic heart failure in the elderly patients. Methods Serum level of cTnT, and serum activities of ereatine kinase (CK) and ereatine kinase-MB (CK-MB) were measured in 60 elderly patients of chronic heart failure with varied classes of cardiac function. Cardiac events, including malignant cardiac arrhythemia, repeated or aggravated heart failure or cardiac death, in patients with increased cTnT during hospitalization were compared to those without it. Results Serum level averaged ( 89.1 ± 13.6) mmol/L for CK and (7.9 ± 1.4) mmol/L for CK-MB in 20 patients with Class II cardiac function by New York Heart Association (NYHA) classification and without increased cTnT, (88.2 ± 13.4) mmol/L for CK and (7.5 ± 1.8) mmol/L for CK-MB in 19 patients with Class Ⅲ cardiac function and four of them with increased cTnT, and (93.3 ± 14.2) mmol/L for CK and (8.1 ± 1.6) mmol/L for CK-MB in 21 patients with Class Ⅳ cardiac function and 14 of them with increased cTnT. Malignant cardiac arrhythemia occurred in six, repeated heart failure in eight, and death in three of 18 patients with increased cTnT, and one, two and one in 22 patients without increased cTnT, respectively. Incidence of cardiac events was higher in patients with increased cTnT than those without it ( P 〈 0. 05 ). Conclusions Serum level of cTnT is associated closely with the prognosis in the elderly patients with chronic heart failure, which can be used as a prognosis predicting indicator for them.
出处 《中华全科医师杂志》 2007年第5期278-279,共2页 Chinese Journal of General Practitioners
关键词 心力衰竭 肌钙蛋白T 预后 Heart failure, chronic Troponin T Prognosis
  • 相关文献

参考文献3

二级参考文献26

  • 1[1]Katus HA, Looser S, Hallermayer K, et al.Clin Chem, 1992; 38(3) :386~393
  • 2[2]Coudrey L. Arch Intern Med,1998;158(11):1173~ 1180
  • 3[3]Adams JE, Abendschein DR, Jaffe AS, et al.Circulation, 1993; 88 (2): 750 ~ 763
  • 4[4]Pierce GF, Jaffe AS. Clin Chem,1986;32(1):2044 ~2051
  • 5[5]Adams JE, Bodor GS, Davila Roman VG, et al. Circulation, 1993; 88(1): 101~ 106
  • 6[6]Mair J, Artner Dworzak E, Lechleitner P, et al. Clin Chem, 1991; 37(6):845~852
  • 7[7]Ricchiuti V, Voss EM, Ney A, et al. Clin Chem, 1998; 44(9): 1919~1924
  • 8[8]Burlina A, Zaninotto M, Secchiero S, et al.Clin Biochem, 1994; 27(2): 113~ 121
  • 9[9]Giraldi F, Gmzi S, Guazzi MD, et al. Cardiologia, 1998; 43(5) :485~491
  • 10[10]Stejskal D, Horalik D, Bartek J, et al. Vnitr Lek, 1998; 44(7):391~395

共引文献46

同被引文献15

  • 1BOER RA, VOORS AA, MUNTENDAM P, et al. Galecfin-3: a novel mediator of heart failure development and progression[J]. Eur J Heart Fail, 2009, 11(9): 811-817.
  • 2HENDERSON NC, SETHI T. The regulation of inflammation by galectin-3[J]. Immunol Rev, 2009, 230(1): 160-171.
  • 3FUJIU K, NAGAI R. Contributions of cardiomyocyte-eardiae fi- broblast-immune een nteraetions in heart failure development[J]. Basic Res Cardiol, 2013, 108(4): 357.
  • 4CHRISTENSON RH, DUH SH, WU AHB, et al. Multi-center determination of galeetin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure [J]. Clin Biochem, 2010, 43(7/8): 683-690.
  • 5HORWICH TB, FONAROW GC, HAMILTON MA, et al. Anemia is associated with worse symptoms, greater impairment in func- tional capacity and a significant increase in mortality in patients with advanced heart failure[J]. J Am Coil Cardiol, 2002, 39(11): 1780-1786.
  • 6KANSAGARA D, DYER E, ENGLANDER H, et al. Treatment of anemia in patients with heart disease: a systematic view[J]. Ann Intern Med, 2013, 159(11): 746-757.
  • 7TANG YD, KATZ SD. The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes[J]. Heart Fail Rev, 2008, 13(4): 387-392.
  • 8MILOVANOVIC M, PESIC G, NIKOLIC V, et al. Vitamin D deficiency is associated with increased IL-17 and TNF-ct lev- els in patients with chronic heart failu[J]. Arq Bras Cardiol, 2012, 98(3): 259-265.
  • 9CONRAADS VM, BOSMANS JM, SCHUERWEGH AJ, et al. Intracellular monocyte cytokine production and CD14 expression are up-regulated in severevs mild chronic heart failure[J]. Heart Lung Transplant, 2005, 24(7): 854-859.
  • 10GAERTNER R, LEPAILLEUR-ENOUF D, GONZALEZ W, et al. Pulmonary endothelium as a site of synthesis and storage of interleukin-6 in experimental congestive heart failure[J]. Eur J Heart Fail, 2003, 5(4): 435-442.

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部